Document Detail


Neurofilament heavy-chain NfH(SMI35) in cerebrospinal fluid supports the differential diagnosis of Parkinsonian syndromes.
MedLine Citation:
PMID:  17013909     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We aimed to evaluate the potential of the cerebrospinal fluid (CSF) axonal damage biomarker NfH(SMI35) in the laboratory-supported differential diagnosis of parkinsonian syndromes. Patients with idiopathic Parkinson's disease (PD; n = 22), multiple-system atrophy (MSA; n = 21), progressive supranuclear palsy (PSP; n = 21), corticobasal degeneration (CBD; n = 6), and age-matched controls (n = 45) were included. CSF levels of NfH(SMI35) were measured using ELISA. Levels of CSF NfH(SMI35) were elevated in PSP compared to PD and controls (P < 0.05 each). They were also significantly higher in MSA than in PD and controls (P < 0.05 each). NfH(SMI35) differentiated PD from PSP with a sensitivity of 76.5% and a specificity of 94.4%. Axonal damage as measured by CSF NfH(SMI35) is most prominent in the more rapidly progressive syndromes PSP and MSA as compared to PD or CBD. CSF NfH(SMI35) may therefore be of some value for the laboratory-supported differential diagnosis of atypical parkinsonian syndromes.
Authors:
Johannes Brettschneider; Axel Petzold; Sigurd D Süssmuth; Georg B Landwehrmeyer; Albert C Ludolph; Jan Kassubek; Hayrettin Tumani
Related Documents :
21204809 - Status epilepticus in fragile x syndrome.
3497719 - The multiple manifestations of the encephalocraniocutaneous lipomatosis syndrome.
16929879 - Not your typical strongyloides infection: a literature review and case study.
1929929 - Blind spot enlargement as a manifestation of multifocal choroiditis.
3655059 - Ameloblastoma associated with basal cell nevus (gorlin) syndrome: ct findings.
535409 - Espanto: a dialogue with the gods.
19081899 - Periodontal findings and other oral manifestations in proteus syndrome: a case report.
19662319 - Prevalence of congenital heart defects in patients with down syndrome in the municipali...
12665319 - Myelolipomatous foci in an adrenal adenoma causing cushing's syndrome?
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Movement disorders : official journal of the Movement Disorder Society     Volume:  21     ISSN:  0885-3185     ISO Abbreviation:  Mov. Disord.     Publication Date:  2006 Dec 
Date Detail:
Created Date:  2006-12-27     Completed Date:  2007-02-20     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8610688     Medline TA:  Mov Disord     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2224-7     Citation Subset:  IM    
Copyright Information:
Copyright 2006 Movement Disorder Society.
Affiliation:
Department of Neurology, University of Ulm, Ulm, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Case-Control Studies
Diagnosis, Differential
Enzyme-Linked Immunosorbent Assay / methods
Female
Humans
Male
Middle Aged
Multiple System Atrophy / cerebrospinal fluid
Neurofilament Proteins / cerebrospinal fluid*
Parkinsonian Disorders / cerebrospinal fluid*,  diagnosis*
ROC Curve
Supranuclear Palsy, Progressive / cerebrospinal fluid
Chemical
Reg. No./Substance:
0/Neurofilament Proteins; 108688-71-7/neurofilament protein H

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Novel mutation in the ceruloplasmin gene causing a cognitive and movement disorder with diabetes mel...
Next Document:  Effect of a concurrent task on driving performance in people with Parkinson's disease.